Hepatocellular carcinoma - Issues in imaging

Cancer Imaging

Volumn 4, Issue 2, 2004, Pages 174-180

  Thng, C H ^a   Kuo, Y T ^b  

^a DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

CT; Hepatocellular carcinoma; Microbubble; MR; US

Indexed keywords

EID: 79951784732     PISSN: None     EISSN: 14707330     Source Type: Journal    
DOI: 10.1102/1470-7330.2004.0063     Document Type: Article

References (57)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001; 94: 153-6.
2. Szklaruk J, Silverman PM, Charnsangavej C. Imaging in the diagnosis, staging, treatment, and surveillance of hepatocellular carcinoma. AJR Am J Roentgenol 2003; 180: 441-54.
3. Frazer C. Imaging of hepatocellular carcinoma. J Gastroenterol Hepatol 1999; 14: 750-6.
4. Kamel IR, Bluemke DA. Imaging evaluation of hepatocellular carcinoma. J Vasc Interv Radiol 2002; 13: S173-84.
5. Murakami T, Kim T, Nakamura H. Hepatitis, cirrhosis, and hepatoma. J Magn Reson Imaging 1998; 8: 346-58.
6. Ngan H. Imaging and radiological intervention in hepatocellular carcinoma. Hong Kong Med J 1997; 3: 57-68.
7. Yu SC, Yeung DT, So NM. Imaging features of hepatocellular carcinoma. Clin Radiol 2004; 59: 145-56.
8. Thng CH, Kuo Y, Blomley MJ. Imaging hepatocellular carcinoma. Cancer Rev Asia-Pacific 2003; 1: 191-210.
9. Sherman M, Peltekian KM, Lee C. Screening for hepatocellular carcinoma in chronic carriers of hepatitis B virus: incidence and prevalence of hepatocellular carcinoma in a North American urban population. Hepatology 1995; 22: 432-8.
10. Cottone M, Turri M, Caltagirone M et al. Screening for hepatocellular carcinoma in patients with Child's A cirrhosis: an 8-year prospective study by ultrasound and alphafetoprotein. J Hepatol 1994; 21: 1029-34.
11. Sheu JC, Sung JL, Chen DS et al. Growth rate of asymptomatic hepatocellular carcinoma and its clinical implications. Gastroenterology 1985; 89: 259-66.
12. Ebara M, Ohto M, Shinagawa T et al. Natural history of minute hepatocellular carcinoma smaller than three centimeters complicating cirrhosis. A study in 22 patients. Gastroenterology 1986; 90: 289-98.
13. Barbara L, Benzi G, Gaiani S et al. Natural history of small untreated hepatocellular carcinoma in cirrhosis: a multivariate analysis of prognostic factors of tumor growth rate and patient survival. Hepatology 1992; 16: 132-7.
14. Bruix J, Sherman M, Llovet JM et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001; 35: 421-30.
15. Collier J, Sherman M. Screening for hepatocellular carcinoma. Hepatology 1998; 27: 273-8.
16. Honda H, Onitsuka H, Murakami J et al. Characteristic findings of hepatocellular carcinoma: an evaluation with comparative study of US, CT and MRI. Gastrointest Radiol 1992; 17: 245-9.
17. Primary liver cancer in Japan. Clinicopathologic features and results of surgical treatment. Liver Cancer Study Group of Japan. Ann Surg 1990; 211: 277-87.
18. Stevens WR, Johnson CD, Stephens DH, Batts KP. CT findings in hepatocellular carcinoma: correlation of tumor characteristics with causative factors, tumor size, and histologic tumor grade. Radiology 1994; 191: 531-7.
19. Ryder SD. Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults. Gut 2003; 52(Suppl 3): iii1-8.
20. Kim TK, Choi BI, Han JK, Chung JW, Park JH, Han MC. Nontumorous arterioportal shunt mimicking hypervascular tumor in cirrhotic liver: two-phase spiral CT findings. Radiology 1998; 208: 597-603.
21. Itai Y, Matsui O. Blood flow and liver imaging. Radiology 1997; 202: 306-14.
22. Shimizu A, Ito K, Koike S, Fujita T, Shimizu K, Matsunaga N. Cirrhosis or chronic hepatitis: evaluation of small (< or =2-cm) early-enhancing hepatic lesions with serial contrast-enhanced dynamic MR imaging. Radiology 2003; 226: 550-5.
23. Jeong YY, Mitchell DG, Kamishima T. Small (<20 mm) enhancing hepatic nodules seen on arterial phase MR imaging of the cirrhotic liver: clinical implications. AJR Am J Roentgenol 2002; 178: 1327-34.
24. Kanematsu M, Kondo H, Semelka RC et al. Early-enhancing non-neoplastic lesions on gadolinium-enhanced MRI of the liver. Clin Radiol 2003; 58: 778-86.
25. Earls JP, Theise ND, Weinreb JC et al. Dysplastic nodules and hepatocellular carcinoma: thin-section MR imaging of explanted cirrhotic livers with pathologic correlation. Radiology 1996; 201: 207-14.
26. Ngan H. Lipiodol computerized tomography: how sensitive and specific is the technique in the diagnosis of hepatocellular carcinoma? Br J Radiol 1990; 63: 771-5.
27. Sherman M. Alphafetoprotein: an obituary. J Hepatol 2001; 34: 603-5.
28. Trevisani F, D'Intino PE, Morselli-Labate AM et al. Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status. J Hepatol 2001; 34: 570-5.
29. Vauthey JN, Lauwers GY, Esnaola NF et al. Simplified staging for hepatocellular carcinoma. J Clin Oncol 2002; 20: 1527-36.
30. Okuda K, Ohtsuki T, Obata H et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer 1985; 56: 918-28.
31. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003; 362: 1907-17.
32. Freeny PC, Grossholz M, Kaakaji K, Schmiedl UP. Significance of hyperattenuating and contrast-enhancing hepatic nodules detected in the cirrhotic liver during arterial phase helical CT in pre-liver transplant patients: radiologic-histopathologic correlation of explanted livers. Abdom Imaging 2003; 28: 333-46.
33. Lim JH, Cho JM, Kim EY, Park CK. Dysplastic nodules in liver cirrhosis: evaluation of hemodynamics with CT during arterial portography and CT hepatic arteriography. Radiology 2000; 214: 869-74.
34. Yu JS, Kim KW, Jeong MG, Lee JT, Yoo HS. Nontumorous hepatic arterial-portal venous shunts: MR imaging findings. Radiology 2000; 217: 750-6.
35. Mori K, Yoshioka H, Itai Y et al. Arterioportal shunts in cirrhotic patients: evaluation of the difference between tumorous and nontumorous arterioportal shunts on MR imaging with superparamagnetic iron oxide. AJR Am J Roentgenol 2000; 175: 1659-64.
36. Burrel M, Llovet JM, Ayuso C et al. MRI angiography is superior to helical CT for detection of HCC prior to liver transplantation: an explant correlation. Hepatology 2003; 38: 1034-42.
37. Anthony PP. Tumours and tumour-like lesions of the liver and biliary tract: aetiology, epidemiology and pathology. In: Pathology of the liver, 4th edition. MacSween RNM, Burt AD, Portmann BC, Ishak KG, Scheuer PJ, Anthony PP, eds. Edinburgh: Churchill Livingstone, 2002: 711-75.
38. Lim AK, Patel N, Gedroyc WM, Blomley MJ, Hamilton G, Taylor-Robinson SD. Hepatocellular adenoma: diagnostic difficulties and novel imaging techniques. Br J Radiol 2002; 75: 695-9.
39. Sakamoto M, Hirohashi S, Shimosato Y. Early stages of multistep hepatocarcinogenesis: adenomatous hyperplasia and early hepatocellular carcinoma. Hum Pathol 1991; 22: 172-8.
40. Hayashi M, Matsui O, Ueda K et al. Correlation between the blood supply and grade of malignancy of hepatocellular nodules associated with liver cirrhosis: evaluation by CT during intraarterial injection of contrast medium. AJR Am J Roentgenol 1999; 172: 969-76.
41. Krinsky GA, Nguyen MT, Lee VS et al. Dysplastic nodules and hepatocellular carcinoma: sensitivity of digital subtraction hepatic arteriography with whole liver explant correlation. J Comput Assist Tomogr 2000; 24: 628-34.
42. Rode A, Bancel B, Douek P et al. Small nodule detection in cirrhotic livers: evaluation with US, spiral CT, and MRI and correlation with pathologic examination of explanted liver. J Comput Assist Tomogr 2001; 25: 327-36.
43. Krinsky GA, Lee VS, Theise ND et al. Hepatocellular carcinoma and dysplastic nodules in patients with cirrhosis: prospective diagnosis with MR imaging and explantation correlation. Radiology 2001; 219: 445-54.
44. Onaya H, Itai Y. MR imaging of hepatocellular carcinoma. Magn Reson Imaging Clin N Am 2000; 8: 757-68.
45. Matsui O, Kadoya M, Kameyama T et al. Benign and malignant nodules in cirrhotic livers: distinction based on blood supply. Radiology 1991; 178: 493-7.
46. Yamashita Y, Mitsuzaki K, Yi T et al. Small hepatocellular carcinoma in patients with chronic liver damage: prospective comparison of detection with dynamic MR imaging and helical CT of the whole liver. Radiology 1996; 200: 79-84.
47. Oi H, Murakami T, Kim T, Matsushita M, Kishimoto H, Nakamura H. Dynamic MR imaging and early-phase helical CT for detecting small intrahepatic metastases of hepatocellular carcinoma. AJR Am J Roentgenol 1996; 166: 369-74.
48. Kanematsu M, Hoshi H, Murakami T et al. Detection of hepatocellular carcinoma in patients with cirrhosis: MR imaging versus angiographically assisted helical CT. AJR Am J Roentgenol 1997; 169: 1507-15.
49. Murakami T, Kim T, Oi H et al. Detectability of hypervascular hepatocellular carcinoma by arterial phase images of MR and spiral CT. Acta Radiol 1995; 36: 372-6.
50. Choi D, Kim SH, Lim JH et al. Detection of hepatocellular carcinoma: combined T2-weighted and dynamic gadolinium-enhanced MRI versus combined CT during arterial portography and CT hepatic arteriography. J Comput Assist Tomogr 2001; 25: 777-85.
51. Kondo H, Kanematsu M, Hoshi H et al. Preoperative detection of malignant hepatic tumors: comparison of combined methods of MR imaging with combined methods of CT. AJR Am J Roentgenol 2000; 174: 947-54.
52. Jang HJ, Lim JH, Lee SJ, Park CK, Park HS, Do YS. Hepatocellular carcinoma: are combined CT during arterial portography and CT hepatic arteriography in addition to triplephase helical CT all necessary for preoperative evaluation? Radiology 2000; 215: 373-80.
53. Takayasu K, Shima Y, Muramatsu Y et al. Angiography of small hepatocellular carcinomas: analysis of 105 resected tumors. AJR Am J Roentgenol 1986; 147: 525-9.
54. Harvey CJ, Lim AK, Blomley MJ, Taylor-Robinson SD, Gedroyc WM. Cosgrove DO. Detection of an occult hepatocellular carcinoma using ultrasound with liver-specific microbubbles. Eur Radiol 2002; 12(Suppl 3): 70-3.
55. Bartolozzi C, Lencioni R, Ricci P, Paolicchi A, Rossi P, Passariello R. Hepatocellular carcinoma treatment with percutaneous ethanol injection: evaluation with contrast-enhanced color Doppler US. Radiology 1998; 209: 387-93.
56. Choi D, Lim HK, Kim SH et al. Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: usefulness of power Doppler US with a microbubble contrast agent in evaluating therapeutic response - preliminary results. Radiology 2000; 217: 558-63.
57. Wen YL, Kudo M, Zheng RQ et al. Radiofrequency ablation of hepatocellular carcinoma: therapeutic response using contrastenhanced coded phase-inversion harmonic sonography. AJR Am J Roentgenol 2003; 181: 57-63.